Lexicon Pharmaceuticals Inc (LXRX) Directors and Executive Officers

Officers & Directors

1. Lonnel Coats, Chief Executive Officer and Director (Principal Executive Officer)

2. Jeffrey L. Wade, President and Chief Financial Officer (Principal Financial Officer)

3. Kristen L. Alexander, Vice President, Finance and Accounting (Principal Accounting Officer)

4. Robert J. Lefkowitz, Director

5. Christopher J. Sobeki, Director

6. Raymond Debbane, Chairman of the Board of Directors

7. Samuel L. Barker, Director

8. Diane E. Sullivan, Director

9. Judith L. Swain, Director

10. Philippe J. Amouyal, Director,

Lexicon Pharmaceuticals Inc currently has 81 employees.

News about Lexicon Pharmaceuticals Inc Key Personnel

Lexicon Pharmaceuticals Financial Strains Persist Even as FDA Advisory Committee Approves Zynquista for Diabetes Management,

Lexicon Pharmaceuticals Faces Financial Headwinds Amid FDA Advisory Approval for Zynquista Amid a backdrop of significant financial challenges, Lexicon Pharmaceuticals Inc. recently announced the outcome of an FDA Advisory Committee meeting concerning Zynquista (sotagliflozin), as an adjunct to insulin therapy for managing glycemic control in adults with Type 1 diabetes and chronic kidney disease. The PDUFA (Prescription Drug User Fee Act) target action date for the drug has been set for December 20, 2024, injecting a glimmer of hope into the beleaguered company’s prospects. Despite the favorable advisory committee outcome, Lexicon’s struggles are starkly evident in its financial reports. The company r...